Business and Finance

Most proposed solutions are already in the works

Another attempt by payers to control their healthcare costs; possible broader implications

Deal brings Celgene into the CAR-T arena

Acquired company lasted less than a year after Biogen spinoff

HDA 2017-8 Factbook details rising wholesaler involvement

Acquisition brings retail pharmacy and PBM together with a health insurer

Private equity firm acquires UBC

The Netherlands wins out in the competition to move the agency from London

$815-million deal to close in early 2018

Rumors of a $60-billion acquisition shake up healthcare services landscape—and what about Amazon?

New identity stresses ‘human data science’

Revised deal brings 1,932 stores to Walgreens Boots Alliance

Bloomington, IN, facility is the prize

‘An unaffordable drug is 100 percent ineffective’

First gene therapy product in US; approval expedited by evidence of high cure rates

Investors hope for a repeat of Gilead’s Sovaldi success

Observers are critical of the $465-million penalty as too lenient

Leading CRO looks to better trial recruitment, outcomes research

A protest against not protesting; unclear consequences for pharma’s place on the White House council

New location, following Brexit, will be decided in November

GPO for academic medical centers and other providers

Cambridge BioMarketing brings orphan-drug expertise, and Vynamic brings branding and launch services